ClinicalTrials.gov
public full text
Public Domain
A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes
The purpose of this study are to determine whether a test dose program for taxanes will reduce the rate and/or severity of hypersensitivity reactions (HSR); and to determine whether a test dose program for taxanes will result in cost reduction due to decreased drug wastage.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Optimal Doses for Drug Provocation Tests to Beta-lactams#841513
- Randomized optimal selection design for dose optimization.#193710
- Whole Brain Radiation Using IMRT for Patients With Brain Metastases#872474
- A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers#879801
- Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment#1010804
Record · ID 980676
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive